U.S. Infrastructure Stock News

Conference update and pipeline focus Corvus Pharmaceuticals (CRVS) has come into focus after its appearance at the Oppenheimer 36th Annual Healthcare Life Sciences Conference, where management outlined fresh details on lead candidate soquelitinib across several immune related indications. The company highlighted plans for a phase III interim analysis in peripheral T cell lymphoma by year end 2026, new phase II studies in asthma and hidradenitis suppurativa, and early atopic dermatitis data...

Central Garden & Pet reported a 6% year over year revenue decline in its latest quarter. The company expanded its share repurchase program, signaling an increased focus on buybacks. Central Garden & Pet also refreshed its board of directors with new appointments. Central Garden & Pet, traded as NasdaqGS:CENT, released results that showed weaker revenue and earnings alongside the slowest revenue growth among its household product peers. The stock last closed at $39.18 and is up 22.1% over...

If you are wondering whether Universal Health Services is attractively priced or starting to look expensive, you are in the right place for a clear look at what the market might be implying about its value. The shares last closed at US$206.10, with returns of a 10.6% decline over 7 days, 1.5% over 30 days, a 6.3% decline year to date, 18.1% over 1 year, 64.2% over 3 years, and 61.1% over 5 years. This gives you a broad sense of how sentiment around the stock has shifted over time. Recent...

ON Semiconductor is sharpening its focus on higher margin areas, including silicon carbide products and AI data center power solutions. The company is reallocating capital toward projects it views as higher return and scaling back exposure to weaker end markets such as electric vehicles and smartphones. Management is emphasizing capital discipline and targeted investment as it reshapes the business mix of NasdaqGS:ON. For investors tracking NasdaqGS:ON, this reset comes with the stock...

Coastal Financial recently reported a past-quarter update showing a 1.3% year-on-year revenue decline, missing analysts’ expectations by 16.6%, even as loans receivable grew 1.2% and deposits rose 4.3%. Management emphasized the potential of its Banking-as-a-Service platform, highlighting plans to expand product offerings and scale new and existing partnerships despite the disappointing revenue and net interest income performance. We’ll now examine how Coastal Financial’s revenue shortfall...

Vera Therapeutics reported full-year 2025 results showing a net loss of US$299.62 million, while advancing atacicept with positive Phase 3 IgA nephropathy data and securing FDA priority review with a July 7, 2026 PDUFA date. Alongside filing a US$191.89 million Class A common stock shelf registration for an ESOP-related offering, the company highlighted that its cash, equivalents, marketable securities and debt facility availability are expected to fund operations through potential atacicept...

Pulse Biosciences, Inc. reported a full-year 2025 net loss of US$72.78 million, widening from US$53.59 million in 2024, and filed new universal and ESOP-related shelf registrations alongside a reconfigured at-the-market common stock offering. At the same time, FDA approval to begin a paroxysmal atrial fibrillation study with the nPulse Cardiac Catheter System and a planned thyroid cancer collaboration with The University of Texas MD Anderson Cancer Center underscore how the company is...

The Honest Company, Inc. recently reported that full-year 2025 sales slipped to US$371.32 million while net loss more than doubled to US$15.69 million, and simultaneously announced a new US$25 million share repurchase program funded by cash on hand and operating cash flows. Alongside this, management issued 2026 guidance calling for an anticipated high-teens percentage decline in reported revenue due to exited categories, while emphasizing 4% to 6% organic growth as the core metric of its...

In February 2026, Verizon Communications Inc. completed the sale of €2.25 billion and £600 million of junior subordinated unsecured notes due 2056, including step-up and fixed-to-floating rate Eurobonds that are callable and carry a 0.65% discount to par. This move adds long-dated, junior capital to Verizon’s balance sheet, potentially supporting funding for network investment and ongoing transformation without immediately relying on common equity. We’ll now examine how this large junior...

What Southwest Airlines (LUV) investors may be watching now Recent trading in Southwest Airlines (LUV) has drawn attention after a sharp move in the share price over the past month and past 3 months, prompting investors to reassess the airline’s current valuation and fundamentals. See our latest analysis for Southwest Airlines. At a share price of US$49.26, Southwest Airlines has seen a 30 day share price return of 20.56% and a 90 day share price return of 41.51%, while the 1 year total...

If you are wondering whether Evercore's current share price fairly reflects its underlying worth, you are not alone. This article is designed to help you size that up clearly. The stock last closed at US$308.84, with returns of 29.2% over 1 year and a 144.5% gain over 3 years, even though the past 7 days and 30 days show declines of 5.9% and 15.0% and the year to date return sits at a 12.1% decline. Recent coverage has focused on Evercore's role as a major independent investment bank in...

In February 2026, Sezzle Inc. reported full-year 2025 results showing sales of US$450.28 million and net income of US$133.13 million, alongside guidance for 2026 calling for total revenue growth of 25% to 30% and the launch of Sezzle Mobile, an integrated unlimited phone plan starting at US$29.99 per month within its app. These updates highlight Sezzle’s shift from a pure buy-now-pay-later platform toward a broader financial and everyday-spending hub, with subscription, payments, and now...

In recent months, Quantum Computing Inc. (QCi) raised US$1.25 billion in cash, closed a US$110.0 million acquisition of Luminar Semiconductor, secured contracts with NASA and NIST, completed a quantum photonic chip foundry in Tempe, Arizona, and announced it would report Q4 and full-year 2025 results on March 2, 2026. These moves, alongside the company’s first U.S. commercial sale of quantum cybersecurity solutions to a top-five bank and growing Department of Defense work, highlight QCi’s...

Symbotic (SYM) is back in focus after reporting first quarter results that exceeded expectations on both profitability and revenue, supported by improved margins and what management describes as strong operational execution. See our latest analysis for Symbotic. At a share price of $54.78, Symbotic has seen a 90 day share price return decline of 34.61%. Its 1 year total shareholder return of 141.32% and 3 year total shareholder return of about 3.3x point to strong longer term momentum despite...

If you are wondering whether Vistance Networks at around US$17.57 still offers value after a strong run, this article will help you size up the price against the fundamentals. The stock has pulled back with a 7.4% decline over the last week and a 6.5% decline over the last 30 days, yet it still sits on a 176.7% return over the past year and 125.3% over three years. Recent price moves come as the market continues to react to ongoing news flow around Vistance Networks, including growing...

Enact Holdings, Inc. has recently outlined in its 2025 10-K a new US$350 million share repurchase authorization and a US$435 million revolving credit facility, alongside continued plans to return capital via dividends and buybacks while supporting its U.S. mortgage insurance operations. Analyst sentiment has shifted as Enact was elevated to a Zacks Rank #1 (Strong Buy) on the back of higher earnings estimates, underscoring how its capital return plans and financing flexibility are...

Nexstar Media Group (NXST) just posted fourth quarter 2025 results that came in ahead of earnings estimates, even as revenue and profitability trailed the prior year and put renewed focus on its distribution and digital plans. See our latest analysis for Nexstar Media Group. Nexstar’s earnings beat and progress on renewing distribution deals arrives alongside strong recent momentum, with a 30 day share price return of 21.08% and a 1 year total shareholder return of 53.99% pointing to rising...

In late February 2026, Marsh & McLennan Companies’ board declared a US$0.900 quarterly dividend per share and secured a court injunction protecting its confidential information, while also adding experienced investment executive Peter Harrison to its now 13‑member board. Together, the legal victory, board refresh, and continued capital return program underscore how Marsh & McLennan is reinforcing both its governance framework and protection of core client and data relationships. We’ll now...

Teekay Tankers Ltd. reported past fourth quarter 2025 revenue of US$258.27 million, with net income rising to US$120.46 million and diluted earnings per share from continuing operations of US$3.46, while full-year 2025 revenue was US$951.80 million and net income was US$351.19 million. Despite lower full-year revenue and earnings compared with the prior year, the company’s stronger quarterly profitability and the Board’s decision to maintain a regular US$0.25 per-share cash dividend for the...

Albertsons Companies (NYSE:ACI) has appointed experienced technology executive Brian Rice to its Board of Directors. Rice brings a background in digital transformation, technology leadership, and global supply chain operations at major consumer brands including McDonald's. The board change highlights a focus on technology, digital engagement, and cybersecurity for the grocery retailer. Albertsons, one of the largest food and drug retailers in the United States, operates a wide network of...

Nordson (NasdaqGS:NDSN) reported strong Q1 earnings, followed by several analyst upgrades. Shortly after these results, the CEO and Executive Vice President executed significant insider share sales. The timing of these transactions, coming on the heels of upbeat quarterly news, has drawn investor attention. Nordson, a producer of precision dispensing and related technologies, operates at the intersection of industrial, electronics, and consumer end markets. Many of its customers use Nordson...

Nordic American Tankers (NAT) has rounded out FY 2025 with Q4 revenue of US$59.5 million and net income of US$11.7 million, equal to EPS of about US$0.06, against a trailing 12 month EPS figure of roughly US$0.06 on revenue of US$183.3 million. The company has recorded quarterly revenue between US$37.9 million and US$59.5 million over 2025, while EPS has ranged from a small loss of about US$0.01 to a gain of roughly US$0.06. This has set up a results season in which investors are paying close...

In recent months, Viking Therapeutics has advanced its dual GLP-1/GIP obesity candidate VK2735 into late-stage trials while a rival program, Novo Nordisk’s CagriSema, missed a key goal in late-stage testing. This combination of competitor setbacks and Viking’s progress, including plans for both injectable and oral VK2735 formulations, has sharpened investor focus on the company’s role in the obesity treatment race. With VK2735 moving into phase 3 trials, we’ll now examine how this...

In recent days, Glacier Bancorp was caught up in a broader selloff of regional banks after hotter‑than‑expected January Producer Price Index data heightened concerns about persistent inflation and credit risks. This bout of risk aversion has pushed investors to scrutinize how exposed banks like Glacier are to cyclical sectors, private credit, and leveraged loans. We’ll now examine how renewed worries about sticky inflation and credit risk could influence Glacier Bancorp’s previously...